RecruitingNCT07478029

Clinical Study of PEG Bowel Preparation in Appendectomy Patients

Impact of Polyethylene Glycol (PEG) Bowel Preparation on Intestinal Microbiota Composition and Diversity in Patients Undergoing Appendectomy


Sponsor

Huaping Xie

Enrollment

10 participants

Start Date

Feb 23, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Colonoscopy is a necessary item of physical examination for colorectal cancer. For high-risk groups, annual physical examination is the most effective way of early prevention; At present, a large amount of polyethylene glycol (PEG2000 - 4000) is often used as laxative and lubricant in colonoscopy. However, the widespread use of PEG may cause long-term and irreversible damage to intestinal microorganisms and bring great hidden dangers to health. The appendix has long been regarded as a redundant organ in evolution. The incidence of appendicitis ranks first in surgical acute abdomen. Traditionally, once acute appendicitis is diagnosed, it is usually treated with appendectomy. However, recent studies have revealed that appendectomy may be associated with psychiatric diseases, colorectal cancer, cardiovascular diseases and other diseases. The appendix is not only an important organ of the immune system, but also undertakes the function of storing and protecting intestinal microbes.. . This change may affect the function of the central nervous system through the microbe gut brain axis, and then pose a potential threat to the health and behavior of the host, such as increasing the risk of diseases such as Parkinson's disease. Based on this, this clinical trial aims to investigate (1) the changes of intestinal flora in the appendectomy population before and after colonoscopy in the process of polyethylene glycol intestinal preparation; (2) the differences between the changes of intestinal flora before and after colonoscopy in the appendicectomy population and the normal population in the process of flora recovery.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria5

  • Aged 18-75 years.
  • Scheduled to undergo colonoscopy.
  • Generally healthy without major organ diseases.
  • For appendectomy group: history of appendectomy or right hemicolectomy (including appendectomy).
  • For control group: no history of appendectomy or right hemicolectomy.

Exclusion Criteria6

  • Allergy or intolerance to PEG laxatives.
  • Pregnant or lactating women.
  • Mental disorders.
  • Use of antibiotics within 6 months prior to study enrollment.
  • Contraindications to colonoscopy (e.g., severe cardiopulmonary insufficiency).
  • For control group only: presence of organic diseases.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGBowel Preparation with Polyethylene Glycol (PEG) Laxatives

All subjects will undergo bowel preparation by taking Polyethylene Glycol (PEG) electrolyte powder according to the clinical routine requirements for colonoscopy. The specific dosage and administration will follow the hospital's standardized protocol. Researchers will record the usage of PEG.


Locations(1)

Department of Gastroenterology Tongji Hospital, Tongji Medical college, Huazhong University of Science and technology

Wuhan, Hubei, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07478029


Related Trials